VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 178 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $421,701 | -37.6% | 97,616 | -4.8% | 0.13% | -23.8% |
| Q2 2023 | $675,660 | -19.6% | 102,528 | -17.2% | 0.17% | -58.7% |
| Q1 2023 | $840,582 | -16.6% | 123,797 | -9.2% | 0.42% | +11.5% |
| Q4 2022 | $1,007,442 | -79.1% | 136,325 | -72.1% | 0.37% | -75.7% |
| Q3 2022 | $4,831,000 | -9.4% | 488,965 | 0.0% | 1.54% | -23.3% |
| Q2 2022 | $5,330,000 | +190.0% | 488,965 | +200.9% | 2.00% | +229.3% |
| Q1 2022 | $1,838,000 | -9.1% | 162,478 | -22.3% | 0.61% | +52.0% |
| Q3 2020 | $2,021,000 | +22.6% | 209,205 | +45.2% | 0.40% | -16.8% |
| Q2 2020 | $1,649,000 | -77.9% | 144,114 | -80.0% | 0.48% | -80.8% |
| Q1 2020 | $7,472,000 | – | 721,193 | – | 2.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |